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E J C S U P P L E M E N T S 4 ( 2 0 0 6 ) 2 7 –5 3 47sion varies depending on the histological type of NSCLC. Identifi-
cation of tumor immunophenotype makes possible to obtain
more data about metastasis potential, malignancy rate and prog-
nosis. This molecular markers panel can be used for early detec-
tion of LC recurring and metastasis.
doi:10.1016/j.ejcsup.2006.04.114
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Background: While in cancer from colon and ovary number and
reactivity of tumor infiltrating lymphocytes (TILs) were associated
with survival, in NSCLC, the clinical significance of TILs is
unknown. While TILs demonstrated antigen specific Interferon
(IFN)-c secretion and cytotoxicity in vitro, their in situ activation
status remains difficult to determine. Here, we examine molecu-
lar assessment of CD8+ T cell reactivity in NSCLC.
Methods: We determined CD8+ T cell counts in 19 patients with
NSCLC by immunohisto-chemistry and assessed T-cell immune
reactivity by measuring mRNA IFN-c levels by quantitative RT-
PCR (TaqMan) from corresponding tissue. CD8+ T cells were clas-
sified into two groups: Intra-tumoral (distributed in cancer cell
nests and stroma) and peri-tumoral (presented along the invasive
margin). Five hpf were evaluated per each localization (IT and PT,
respectively). Distribution of CD8+ T cells was semi-quantitatively
classified into: 0-none or mild; I-moderate; II-severe. The relation-
ship between the median CD8+ T cell density/hpf and the CD8-
normalized IFN-c mRNA expression was tested (Spearman’s
correlation).
Results: Semi-quantitative analysis revealed significantly higher
CD8+ T cell counts within the tumor compared to the invasive
margin (p < 0.001). However, immune activation status of TILs
represented as IFN-c/CD8 ratio was higher in the peri-tumoral
than in the intra-tumoral compartments (p = .022).
Conclusion: In human NSCLC, IFN-c reactivity of CD8+ T cells is
mostly attributed to the tumor–host interface and indicates an
inadequate activation of TILs within the tumor. This methodology
can be applied to a variety of experimental trials if tumor tissue is
available.
doi:10.1016/j.ejcsup.2006.04.115
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of Cologne, Germany.Background: Cyclooxygenase-2 (COX-2) mRNA expression is
known to be progressively increased in the metaplasia–dyspla-
sia–adenocarcinoma (MDA) sequence of Barrett’s cancer (BC)
development. Much less however, is known about COX-2 mRNA
expression in patients with gastroesophageal reflux disease
(GERD).
Methods: Endoscopic biopsies from 3 patient groups were ana-
lyzed: 43 patients undergoing evaluation for GERD (20 GERD posi-
tive/23 GERD negative) by 24-h pH-monitoring, 20 patients with
Barrett’s esophagus (BE) without dysplasia and 47 with BC. COX-
2 mRNA expression was determined by quantitative real-time
RT-PCR (TaqManTM) assays. The Demeester composite score
(DS > 14.72) was used to match COX-2 mRNA expression levels
with the degree of acid exposure.
Results: Median COX-2 mRNA expression was significantly
upregulated in Barrett’s metaplastic epithelium compared to
matched normal squamous epithelium (NE) in the BE (p = 0.03)
and BC group (p = 0.001). COX-2 mRNA expression levels in NE
did not differ significantly between the 3 study groups however,
within the group of patients evaluated for GERD, specimens
obtained from patients with a mean Deemester score >14.72
showed significantly upregulated COX-2 mRNA levels in the distal
acid-exposed esophagus (p = 0.01).
Conclusion: Our findings suggest that the induction of increased
COX-2 mRNA expression occurs already in GERD without the
presence of Barrett’s metaplasia. A field effect as shown for other
genes could not be detected for COX-2 expression in squamous
epithelium in GERD positive, BE or BC patient groups. Chemopre-
vention strategies using selective or non-selective COX-2 inhibi-
tors might be useful in patients with GERD to potentially
prevent the development of Barrett’s metaplasia.
doi:10.1016/j.ejcsup.2006.04.116
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Background: Epidemiological data assume a reduction of risk for
developing an adenocarcinoma of the esophagus for individuals
taking non-steroidal anti-inflammatory drugs. One of the inhib-
ited enzymes, cyclooxygenase-2, is supposed to be involved in
the pathogenesis of Barrett’s cancer. We examined a possible
association between COX-2 protein expression and the progres-
sion of Barrett’s sequence and the type and degree of the environ-
mental inflammatory reaction.
Methods: Squamous epithelium, metaplastic, low-grade and
high-grade dysplastic lesions and tumor tissue of 49 resection
specimens from patients with Barrett’s adenocarcinoma were
analyzed. Immunohistochemical staining was performed with a
